<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04795180</url>
  </required_header>
  <id_info>
    <org_study_id>2011043</org_study_id>
    <nct_id>NCT04795180</nct_id>
  </id_info>
  <brief_title>Pilot Randomized Evaluation of Butyrate Irrigation Before Ileostomy Closure on the Colonic Mucosa in Rectal Cancer Patients (BUTYCLO)</brief_title>
  <acronym>BUTYCLO</acronym>
  <official_title>Pilot Randomized Evaluation of Butyrate Irrigation Before Ileostomy Closure on the Colonic Mucosa in Rectal Cancer Patients: Short-term Outcomes and Microbiota (BUTYCLO)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Low Anterior resection with total mesorectal excision and diversion loop ileostomy is a gold&#xD;
      standard surgical treatment in rectal cancer.&#xD;
&#xD;
      Ileostomy reversal performed in a second stage carries a high burden of postoperative&#xD;
      complications.&#xD;
&#xD;
      Terminal ileum and colon dysfunction during bowel disconnection could negatively influence&#xD;
      postoperative morbimortality after loop ileostomy reversal in Rectal Cancer patients.&#xD;
&#xD;
      Colonic microflora performs anaerobic breakdown of dietary fibre that reaches the gut in&#xD;
      regular patients without ileostomy. One of the short-chain fatty acids (SCFAs) produced by&#xD;
      bacteria is butyrate, the preferred substrate to be oxidized by colonocytes.&#xD;
&#xD;
      The effects of butyrate irrigations before ileostomy closure on colonic mucosa will be&#xD;
      studied in 45 rectal cancer patients.&#xD;
&#xD;
      The effects of butyrate irrigation trough the efferent limb of loop ileostomy before its&#xD;
      closure will be compared to the saline and non-irrigations group.&#xD;
&#xD;
      Short term outcomes, colonic microbiota composition and functional outcomes will be evaluated&#xD;
      after ileostomy reversal.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 10, 2013</start_date>
  <completion_date type="Actual">June 21, 2016</completion_date>
  <primary_completion_date type="Actual">May 17, 2016</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>1 treatment arm open label&#xD;
1 treatment arm double-blind&#xD;
1 treatment arm double-blind</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Postoperative complication rate</measure>
    <time_frame>Within 90 days after surgery</time_frame>
    <description>Rate of medical and surgical complications within 30 days after surgery using the Dindo-Clavien classification, described as:&#xD;
Grade I = Any deviation from the normal postoperative course. Grade 2 = Requiring pharmacological treatment with drugs other than such allowed for grade I complications.&#xD;
Grade III = Requiring surgical, endoscopic or radiological intervention, not under (Grade IIIa) or under general anesthesia (Grade IIIb) Grade IV = Life-threatening complication with single organ (Grade IVa) or Multiorgan dysfunction (Grade IVb) Grade V = Death of a patient.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Length of hospital stay (number of days)</measure>
    <time_frame>Up to 4 weeks</time_frame>
    <description>Total length of hospital stay will be recorded in days beginning at admission for surgery until discharge.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Diversion colitis evaluation trough rectoscopy in colonic mucosa</measure>
    <time_frame>At 5-weeks before surgery, At day before surgery</time_frame>
    <description>Diversion colitis was graded as follows: Grade 0: Normal mucosa, Grade 1: Erythematous mucosa, Grade 2: Erythema and mucosa edema and Grade 3: Spontaneous bleeding or bleeding with the slightest contact with rectoscopy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Identification of microbiota modifications in colonic mucosa after irrigations</measure>
    <time_frame>At 5-weeks before surgery, At day before surgery</time_frame>
    <description>Sequences of the variable portions of the 16s ribosomal RNA gene</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life assessed with Short-Form 36 (SF-36) questionnaire</measure>
    <time_frame>At hospital discharge and at 1 and 3 months after surgery</time_frame>
    <description>This questionnaire taps eight health concepts: physical functioning, bodily pain, role limitations due to physical health problems, role limitations due to personal or emotional problems, emotional well-being, social functioning, energy/tiredness, and general health perceptions. It also includes a single item that provides an indication of a perceived change in health. Score from 0-100</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Anorectal functional outcome assessed by Colorectal Functional Outcome Questionnaire (COREFO) questionnaire</measure>
    <time_frame>At hospital discharge and at 1 and 3 months after surgery</time_frame>
    <description>Alterations in Colorectal Functional Outcome Questionnaire (COREFO) scores. Score from 0-27</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">45</enrollment>
  <condition>Rectal Cancer</condition>
  <arm_group>
    <arm_group_label>Non-irrigations</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No irrigations trough the efferent limb of loop ileostomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Butyrate irrigations</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Butyrate irrigations trough the efferent limb of loop ileostomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Saline irrigations</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Saline irrigations trough the efferent limb of loop ileostomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Irrigations trough the efferent limb of loop ileostomy</intervention_name>
    <description>Irrigations trough the efferent limb of loop ileostomy during 4 weeks previous to ileostomy closure</description>
    <arm_group_label>Butyrate irrigations</arm_group_label>
    <arm_group_label>Saline irrigations</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients over 18 years of age&#xD;
&#xD;
          -  Patients waiting for an elective ileostomy reversal after Rectal cancer surgical&#xD;
             treatment&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inflammatory bowel disease&#xD;
&#xD;
          -  Abnormal preoperative findings trough rectoscopy or CT-enema scan that precluded a&#xD;
             safe ileostomy closure&#xD;
&#xD;
          -  Ileal pouch, poor treatment compliance&#xD;
&#xD;
          -  Pregnancy or lactation&#xD;
&#xD;
          -  Unwillingness to use adequate contraception throughout the study period&#xD;
&#xD;
          -  Combined surgeries&#xD;
&#xD;
          -  The impossibility to understand the informed consent.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital Universitari Dr. Josep Trueta de Girona</name>
      <address>
        <city>Girona</city>
        <zip>17001</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>February 22, 2021</study_first_submitted>
  <study_first_submitted_qc>March 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">March 12, 2021</study_first_posted>
  <last_update_submitted>March 10, 2021</last_update_submitted>
  <last_update_submitted_qc>March 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">March 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta</investigator_affiliation>
    <investigator_full_name>Núria Gómez, MD</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Ileostomy closure</keyword>
  <keyword>Butyrate enemas</keyword>
  <keyword>Microbiota</keyword>
  <keyword>Rectal Cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

